• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC MITRAL BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 310
Device Problem Gradient Increase (1270)
Patient Problems Mitral Regurgitation (1964); Stenosis (2263)
Event Date 07/10/2018
Event Type  Injury  
Manufacturer Narrative
Citation: hu, j.Md et al.Transcatheter mitral valve implantation for degenerated mitral bioprostheses or failed surgical annuloplasty rings: a systematic review and meta-analysis.Journal of cardiac surgery.Sep;33(9):508-519 epub 2018 jul 10.Doi 10.1111/jocs.13767.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via a meta-analysis literature review regarding the implant of transcatheter bioprosthetic valves implanted into failed mitral valves and rings.All data were collected from a pubmed search of articles published between 2000 and march 2018.Sixty-six articles were identified.The overall population included 245 patients.Eighteen patients were implanted with a melody transcatheter bioprosthetic pulmonary valve, implanted in the mitral position.The remaining patients were implanted with a non-medtronic transcatheter bioprosthetic valve.It was reported that the both mosaic and hancock mitral valves had been replaced during the valve-in-valve implants.Serial numbers were not provided.The study population was predominantly male; mean age 73 ± 12.1 years.Among all patients, no deaths were attributed to a medtronic product.Among all patients with a previously implanted mosaic or hancock mitral surgical valve, adverse events included; mitral stenosis, increased mean gradients and mitral regurgitation treated with a valve-in-valve procedure.Based on the available information, these events may have been attributed to a medtronic product.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC MITRAL BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8220684
MDR Text Key132201257
Report Number2025587-2019-00081
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number310
Device Catalogue Number310
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-